VEN Stock Chart & Stats
€87.42
€2.88(3.41%)
At close: 4:00 PM EDT
€87.42
€2.88(3.41%)
Day’s Range― - ―
52-Week Range€56.16 - €87.42
Previous CloseN/A
Volume25.00
Average Volume (3M)29.00
Market Cap
€43.83B
Enterprise Value€52.84K
Total Cash (Recent Filing)€183.61M
Total Debt (Recent Filing)€12.73B
Price to Earnings (P/E)179.5
Beta0.07
Next Earnings
Jul 29, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.56
Shares Outstanding486,169,700
10 Day Avg. Volume41
30 Day Avg. Volume29
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)2.81
Price to Sales (P/S)6.04
P/FCF Ratio26.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€86.79Price Target Upside-0.72% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)0.55
Revenue Forecast (FY)€5.97B
Bulls Say, Bears Say
Bulls Say
Sustained SHOP NOI GrowthVentas has delivered consecutive double-digit SHOP same-store NOI growth, driven by occupancy gains and RevPOR increases. That persistent operating improvement signals a scalable, relationship-driven operating platform that should underpin durable cash flows and FFO growth over multiple quarters.
Improving Cash GenerationOperating and free cash flow trends have strengthened, with OCF roughly 1.21x net income in recent periods and positive FCF growth. Reliable cash generation supports dividends, interest coverage and capital recycling for accretive investments, improving long-term financial resilience.
Strong Liquidity And Active DeploymentA large liquidity cushion plus ~$2.4B of equity funding and active deal execution provide capital flexibility to pursue off-market, relationship-driven acquisitions. This balance of dry powder and disciplined deployment supports scalable growth without immediate refinancing pressure.
Bears Say
Meaningful Leverage And Data InconsistencyDebt-to-equity has historically exceeded 1x (peaking ~1.44) and only improved toward ~1.06, leaving material leverage. High leverage increases sensitivity to rates and limits strategic flexibility. A TTM reporting inconsistency reduces confidence in stated leverage and complicates long-term planning.
Historical Earnings Volatility & Weak MarginsVentas’ bottom-line has been uneven, with prior multiyear net losses and only modest TTM margins. Negative gross profit in recent periods suggests elevated direct costs or reclassifications, constraining durable profitability and limiting returns on an expanded equity base over the medium term.
Execution Risk On Lease-ups & Cap-Rate PressureAcquisitions with material initial vacancy (e.g., Revel) require time and capital to stabilize; simultaneous cap-rate compression from heightened investor demand reduces prospective acquisition yields. Together these factors raise execution and return risk on Ventas’ growth program over coming quarters.
Ventas News
VEN FAQ
What was Ventas’s price range in the past 12 months?
Ventas lowest stock price was €56.16 and its highest was €87.42 in the past 12 months.
What is Ventas’s market cap?
Ventas’s market cap is €43.83B.
When is Ventas’s upcoming earnings report date?
Ventas’s upcoming earnings report date is Jul 29, 2026 which is tomorrow.
How were Ventas’s earnings last quarter?
Ventas released its earnings results on Apr 27, 2026. The company reported €0.097 earnings per share for the quarter, missing the consensus estimate of €0.108 by -€0.011.
Is Ventas overvalued?
According to Wall Street analysts Ventas’s price is currently Overvalued.
Does Ventas pay dividends?
Ventas does not currently pay dividends.
What is Ventas’s EPS estimate?
Ventas’s EPS estimate is 0.12.
How many shares outstanding does Ventas have?
Ventas has 486,169,700 shares outstanding.
What happened to Ventas’s price movement after its last earnings report?
Ventas reported an EPS of €0.097 in its last earnings report, missing expectations of €0.108. Following the earnings report the stock price went up 1.411%.
Which hedge fund is a major shareholder of Ventas?
Currently, no hedge funds are holding shares in DE:VEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ventas Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€86.79 (-0.72% Downside)
€86.79 (-0.72% Downside)
Blogger Sentiment
Bullish
DE:VEN Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $197.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.63%
12-Months-Change
Fundamentals
Return on Equity
2.00%
Trailing 12-Months
Asset Growth
6.35%
Trailing 12-Months
Company Description
Ventas
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
VEN Company Deck
VEN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a strongly positive operational and financial momentum driven by SHOP: double-digit SHOP NOI growth, meaningful occupancy and rate improvements, margin expansion, raised FFO guidance, robust liquidity, and an active, relationship-driven acquisition pipeline (including the $540M Revel value-add acquisition). Risks noted were manageable: Q1 weather-related operating expense pressure, several lease-up assets (including Revel) that need execution, increased transaction competition with cap-rate compression, and dependence on the May–September selling season to sustain full-year targets. On balance, highlights substantially outweighed the lowlights as management increased guidance, strengthened the balance sheet, and articulated a scalable operating platform and pipeline.View all DE:VEN earnings summariesVEN Revenue Breakdown
73.30% SHOP
15.39% OM&R
10.31% NNN
1.00% Non-Segment
VEN Stock 12 Month Forecast
Average Price Target
€86.79
▼(-0.72% Downside)
Technical Analysis
Healthpeak Properties
―
Welltower
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―